Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10165208 | JACC: Heart Failure | 2013 | 7 Pages |
Abstract
These results of the current trial, viewed together with the results from the earlier study, indicate that amlodipine does not exert favorable effects on the clinical course of patients with heart failure, regardless of the presence or absence of underlying coronary artery disease. These findings indicate the need for great caution when striking benefits are observed in subgroups of patients or in trials not primarily designed to assess such effects.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Milton MD, Peter MD, Uri MD, Marvin A. MD, Gordon MD, Christopher MD, Jean-Lucien MD, Douglas MD, Susan A. MS, David L. PhD, PRAISE-2 Study Group PRAISE-2 Study Group,